Peer-reviewedCC BYJournal of Diabetes Investigation
Commentary on: Genetic predictors of GLP1 receptor agonist weight loss and side effects (Nature volume 653, pages 770–775 (2026))
- 1Department of Diabetes and Metabolic Diseases The University of Tokyo Hospital Tokyo Japan
Related
- De-escalating Therapy in Obstructive Sleep Apnoea After Glucagon-Like Peptide-1 Receptor Agonist-Induced Weight Loss: A Narrative Review
- Dietary intake and weight loss in obese adults during GLP-1 receptor agonist treatment
- Glucagon-Like Peptide-1 Receptor Agonist and Gastrointestinal Adverse Effects: A Comprehensive Review Efectos adversos gastrointestinales del agonista del receptor de GLP-1: revisión narrativa
- Novel retinoic acid receptor-related orphan receptor gamma inverse agonist enhances checkpoint blockade in hepatocellular carcinoma: a preclinical mouse study
- Baseline Age Disparities Across GLP‐1 Receptor Agonist–Based Trials
BibTeX
@article{toda2026commentary,
title = {{Commentary on: Genetic predictors of GLP1 receptor agonist weight loss and side effects (Nature volume 653, pages 770–775 (2026))}},
author = {Gotaro Toda and Toshimasa Yamauchi},
journal = {Journal of Diabetes Investigation},
year = {2026},
month = nov,
doi = {10.1111/jdi.70436},
url = {https://doi.org/10.1111/jdi.70436},
note = {CC BY},
}
RIS
TY - JOUR
TI - Commentary on: Genetic predictors of GLP1 receptor agonist weight loss and side effects (Nature volume 653, pages 770–775 (2026))
AU - Gotaro Toda
AU - Toshimasa Yamauchi
PY - 2026
DA - 2026/11/02
JO - Journal of Diabetes Investigation
DO - 10.1111/jdi.70436
UR - https://doi.org/10.1111/jdi.70436
SN - 2040-1124
SN - 2040-1116
ER -